Rhoda Ndamukong
Psychiatric/Mental Health · Waldorf, MDNPI 1477017085
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,626 of the $9,051 with a category attached, or 84.3%. It is spread thinly across 30 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 353 payments — averaging $25.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$1K
- Scilex Pharmaceuticals Inc.$747
- Collegium Pharmaceutical, Inc.$635
- Abbott$566
- plus $3K from 24 others
What the payments were for
- Consulting fees$8009%
- Travel & lodging$6037%
- Food & beverage$7,62684%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 72 | $2,141 |
| Biohaven Pharmaceuticals, Inc. | 25 | $1,208 |
| AbbVie(2 entities) | 68 | $1,196 |
| Scilex Pharmaceuticals Inc. | 38 | $747 |
| Collegium Pharmaceutical, Inc. | 40 | $635 |
| Abbott | 8 | $566 |
| Medtronic | 19 | $561 |
| Pfizer | 18 | $381 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $300 |
| Vertos Medical, Inc. | 4 | $264 |
| Merz North America, Inc. | 1 | $139 |
| Averitas Pharma Inc. | 6 | $136 |
| Amgen(2 entities) | 7 | $112 |
| Nevro Corp. | 5 | $106 |
| Saluda Medical Americas, Inc. | 1 | $80 |
| Lilly USA, LLC | 3 | $67 |
| Biodelivery Sciences International, Inc. | 4 | $57 |
| Relievant Medsystems, Inc. | 1 | $56 |
| Valinor Pharma, LLC | 3 | $52 |
| Merz Pharmaceuticals, LLC | 1 | $47 |
| Hikma Pharmaceuticals USA | 2 | $39 |
| Lundbeck LLC | 1 | $29 |
| TMS Neurohealth Centers Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $23 |
| Biotronik NRO, Inc. | 1 | $15 |
| GRT US Holding, Inc. | 1 | $15 |
| International Rehabilitative Sciences, Inc | 1 | $14 |
| Fidia Pharma USA Inc. | 1 | $14 |
| Corium, LLC | 1 | $13 |
| Redhill Biopharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$800
- PROCLAIM$467
- mild Device Kit$168
- XEOMIN$139
- WaveWriter Alpha Prime 16$121
- INTELLIS ADAPTIVESTIM$102
How this compares
$9,051 in reported general payments places this provider in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 700 | $22,297 |
| Nurtec OdtRimegepant Sulfate | 17 | $17,188 |
| Lidocaine | 174 | $15,291 |
| Diclofenac Sodium | 74 | $11,828 |
| MovantikNaloxegol Oxalate | 27 | $10,965 |
| Xtampza ErOxycodone Myristate | 17 | $9,800 |
| ZtlidoLidocaine | 22 | $9,061 |
| BelbucaBuprenorphine Hcl | 12 | $8,244 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 232 | $7,196 |
| Oxycodone Hcl | 397 | $6,491 |
| Fentanyl | 13 | $6,075 |
| OxycontinOxycodone Hcl | 19 | $5,509 |
| Pregabalin | 172 | $4,064 |
| Gabapentin | 350 | $3,427 |
| Cyclobenzaprine Hcl | 215 | $3,102 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $635 | $18,04429 claims |
| PfizerNurtec Odt | $381 | $17,18817 claims |
| Redhill Biopharma Inc.Movantik | $12 | $10,96527 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $747 | $9,06122 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $39 | $3,77971 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,461 psychiatric/mental health providers in Maryland.
Other psychiatric/mental health in Waldorf
- Hara OyedejiOwings Mills$780K
- Ilya RozenbergGlen Burnie$572K
- Michelle WilliamsColumbia$158K
- Kristin ClemensGaithersburg$36K
- Antonio HeroldHavre de Grace$23K
- Paul KlaverweidenFruitland$17K
- Margaret WebbAberdeen$16K
- Susan KrausTowson$16K
- Anyinke AtabongRockville$15K
- Zenatsehay GebretsadikColumbia$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.